Corient Capital Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.2M | Buy |
3,420
+29
| +0.9% | +$10.2K | 0.09% | 186 |
|
|
2022
Q2 | $1.19M | Buy |
3,391
+502
| +17% | +$176K | 0.09% | 194 |
|
|
2022
Q1 | $1.58M | Buy |
2,889
+1,568
| +119% | +$858K | 0.1% | 175 |
|
|
2021
Q4 | $869K | Sell |
1,321
-32
| -2% | -$21.1K | 0.06% | 250 |
|
|
2021
Q3 | $841K | Buy |
1,353
+101
| +8% | +$62.8K | 0.06% | 241 |
|
|
2021
Q2 | $791K | Buy |
1,252
+86
| +7% | +$54.3K | 0.06% | 255 |
|
|
2021
Q1 | $571K | Buy |
1,166
+209
| +22% | +$102K | 0.05% | 292 |
|
|
2020
Q4 | $478K | Buy |
957
+51
| +6% | +$25.5K | 0.05% | 278 |
|
|
2020
Q3 | $356K | Sell |
906
-110
| -11% | -$43.2K | 0.04% | 304 |
|
|
2020
Q2 | $335K | Buy |
1,016
+120
| +13% | +$39.6K | 0.04% | 310 |
|
|
2020
Q1 | $217K | Buy |
+896
| New | +$217K | 0.03% | 345 |
|
|
2019
Q4 | – | Sell |
-813
| Closed | -$221K | – | 477 |
|
|
2019
Q3 | $221K | Buy |
+813
| New | +$221K | 0.03% | 387 |
|